ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,962,000 | -6.5% | 171,364 | 0.0% | 0.92% | -5.7% |
| Q3 2017 | $2,099,000 | +7.0% | 171,364 | 0.0% | 0.97% | -29.3% |
| Q2 2017 | $1,962,000 | -58.7% | 171,364 | -25.0% | 1.38% | -43.4% |
| Q1 2017 | $4,751,000 | 0.0% | 228,428 | 0.0% | 2.43% | -28.5% |
| Q4 2016 | $4,751,000 | -37.2% | 228,428 | -1.1% | 3.40% | -37.5% |
| Q3 2016 | $7,568,000 | +58.9% | 230,954 | +21.0% | 5.45% | +32.9% |
| Q2 2016 | $4,764,000 | -21.5% | 190,806 | -23.0% | 4.10% | -25.4% |
| Q1 2016 | $6,069,000 | -66.8% | 247,806 | -60.9% | 5.49% | -55.7% |
| Q1 2015 | $18,277,000 | +181.1% | 633,293 | +183.3% | 12.41% | +292.2% |
| Q4 2014 | $6,503,000 | – | 223,553 | – | 3.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |